Targeted Delivery of Quantum Dots to HER2-Expressing Tumor Using Recombinant Antibodies

I. V. Balalaeva, T. A. Zdobnova, E. A. Sokolova, S. M. Deyev

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Targeted delivery of semiconductor quantum dots (Q Ds) to tumors overexpressing HER2 cancer marker has been. demonstrated on immunocompromised mice bearing human breast cancer xenografts. To obtain targeted QDs complexes we applied the approach based on the use of protein adaptor system, RNAase barnase and its inhibitor barstar. Specific binding to target cancer marker was achieved through bivalent fusion protein containing two fragments of4D5scFv recombinant antibody and a fragment of barnase. QDs were conjugated to barstar, and final assembly of targeted complexes was obtained through non-covalent specific interaction of barstar, attached to QD, and barnase, that is part of the recombinant targeting protein. The efficient delivery of QDs to HER2-expressing tumor demonstrates the possibilities and prospects of the approach for targeted delivery of nanoparticles to cancer cells in vivo as the way to improve the efficiency of diagnosis and promote development of therapies based on the use of nanoparticles.

Original languageEnglish
Pages (from-to)599-605
Number of pages7
JournalBioorganicheskaia khimiia
Volume41
Issue number5
Publication statusPublished - 1 Sep 2015

Fingerprint

Quantum Dots
Antibodies
Neoplasms
Nanoparticles
Immunoglobulin Fragments
Semiconductors
Recombinant Proteins
Heterografts
Proteins
Breast Neoplasms
Bacillus amyloliquefaciens barstar protein
Bacillus amyloliquefaciens ribonuclease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Targeted Delivery of Quantum Dots to HER2-Expressing Tumor Using Recombinant Antibodies. / Balalaeva, I. V.; Zdobnova, T. A.; Sokolova, E. A.; Deyev, S. M.

In: Bioorganicheskaia khimiia, Vol. 41, No. 5, 01.09.2015, p. 599-605.

Research output: Contribution to journalArticle

Balalaeva, I. V. ; Zdobnova, T. A. ; Sokolova, E. A. ; Deyev, S. M. / Targeted Delivery of Quantum Dots to HER2-Expressing Tumor Using Recombinant Antibodies. In: Bioorganicheskaia khimiia. 2015 ; Vol. 41, No. 5. pp. 599-605.
@article{45b1cb0d3e754e949fa457bc5d84a7d4,
title = "Targeted Delivery of Quantum Dots to HER2-Expressing Tumor Using Recombinant Antibodies",
abstract = "Targeted delivery of semiconductor quantum dots (Q Ds) to tumors overexpressing HER2 cancer marker has been. demonstrated on immunocompromised mice bearing human breast cancer xenografts. To obtain targeted QDs complexes we applied the approach based on the use of protein adaptor system, RNAase barnase and its inhibitor barstar. Specific binding to target cancer marker was achieved through bivalent fusion protein containing two fragments of4D5scFv recombinant antibody and a fragment of barnase. QDs were conjugated to barstar, and final assembly of targeted complexes was obtained through non-covalent specific interaction of barstar, attached to QD, and barnase, that is part of the recombinant targeting protein. The efficient delivery of QDs to HER2-expressing tumor demonstrates the possibilities and prospects of the approach for targeted delivery of nanoparticles to cancer cells in vivo as the way to improve the efficiency of diagnosis and promote development of therapies based on the use of nanoparticles.",
author = "Balalaeva, {I. V.} and Zdobnova, {T. A.} and Sokolova, {E. A.} and Deyev, {S. M.}",
year = "2015",
month = "9",
day = "1",
language = "English",
volume = "41",
pages = "599--605",
journal = "Bioorganicheskaya Khimiya",
issn = "0132-3423",
publisher = "Izdatel'stvo Nauka",
number = "5",

}

TY - JOUR

T1 - Targeted Delivery of Quantum Dots to HER2-Expressing Tumor Using Recombinant Antibodies

AU - Balalaeva, I. V.

AU - Zdobnova, T. A.

AU - Sokolova, E. A.

AU - Deyev, S. M.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Targeted delivery of semiconductor quantum dots (Q Ds) to tumors overexpressing HER2 cancer marker has been. demonstrated on immunocompromised mice bearing human breast cancer xenografts. To obtain targeted QDs complexes we applied the approach based on the use of protein adaptor system, RNAase barnase and its inhibitor barstar. Specific binding to target cancer marker was achieved through bivalent fusion protein containing two fragments of4D5scFv recombinant antibody and a fragment of barnase. QDs were conjugated to barstar, and final assembly of targeted complexes was obtained through non-covalent specific interaction of barstar, attached to QD, and barnase, that is part of the recombinant targeting protein. The efficient delivery of QDs to HER2-expressing tumor demonstrates the possibilities and prospects of the approach for targeted delivery of nanoparticles to cancer cells in vivo as the way to improve the efficiency of diagnosis and promote development of therapies based on the use of nanoparticles.

AB - Targeted delivery of semiconductor quantum dots (Q Ds) to tumors overexpressing HER2 cancer marker has been. demonstrated on immunocompromised mice bearing human breast cancer xenografts. To obtain targeted QDs complexes we applied the approach based on the use of protein adaptor system, RNAase barnase and its inhibitor barstar. Specific binding to target cancer marker was achieved through bivalent fusion protein containing two fragments of4D5scFv recombinant antibody and a fragment of barnase. QDs were conjugated to barstar, and final assembly of targeted complexes was obtained through non-covalent specific interaction of barstar, attached to QD, and barnase, that is part of the recombinant targeting protein. The efficient delivery of QDs to HER2-expressing tumor demonstrates the possibilities and prospects of the approach for targeted delivery of nanoparticles to cancer cells in vivo as the way to improve the efficiency of diagnosis and promote development of therapies based on the use of nanoparticles.

UR - http://www.scopus.com/inward/record.url?scp=84965190797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965190797&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84965190797

VL - 41

SP - 599

EP - 605

JO - Bioorganicheskaya Khimiya

JF - Bioorganicheskaya Khimiya

SN - 0132-3423

IS - 5

ER -